NAME Dr. Daniel Carter
CANCER TYPE Neuroblastoma
INSTITUTION University of New South Wales
STATE New South Wales
GRANT TYPE $50,000
PROJECT TYPE Research
A novel single-cell transcriptomics drug screen to reveal mechanisms of neuroblastoma drug resistance
This research aims to create an invaluable dataset that applies novel technology to identify mechanisms of drug resistance at the single-cell level, so that we can begin to conceive new therapeutic opportunities to overcome intratumoural heterogeneity.